Differential regulation of 11Ξ²-hydroxyst
β
Shuji Sai; Yuichi Nakagawa; Kimiyoshi Sakaguchi; Shuichi Okada; Hiroyoshi Takaha
π
Article
π
2009
π
Elsevier Science
π
English
β 251 KB
Glucocorticoid therapy forms a crucial first-line treatment for childhood acute lymphoblastic leukemia (ALL). However, glucocorticoid resistance is a therapeutic problem with an unclear molecular mechanism. 11beta-Hydroxysteroid dehydrogenase-1 (11beta-HSD1) is expressed in glucocorticoid target tis